Regencell Bioscience Holdings Limited (RGC)

NASDAQ

$7,09

$-0,17

(-2,38%)

Previous Close: ⁦$7,35⁩

Market Closed

Regencell Bioscience Holdings Limited (RGC) Live Price Chart

Last updated: ⁦2026-10-13 06:12:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Regencell Bioscience Holdings Limited (RGC) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $7,09, with a market capitalisation of $3,64B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,51 to $69,00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3,64B
Open	$7,23
Day's High	$83,60
Day's Low	$0,08
Previous Close	$7,35
Volume	126,59K
Average Volume	186,35K
P/E Ratio	--
52-Week High	$69,00
52-Week Low	$4,51
Dividend Yield	--
Earnings Date	--

Regencell Bioscience Holdings Limited (RGC) Latest Closing Stock Price

Regencell Bioscience Holdings Limited (RGC) last closed at $7,35 as of 2026-10-12 23:41:00, unchanged from the previous close of $7,35.

During the latest regular trading session, RGC traded between $0,08 and $83,60, with a volume of 126,59K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Regencell Bioscience Holdings Limited (RGC) 7-Day Stock Price Change

Over the past seven days, Regencell Bioscience Holdings Limited (RGC) moved from $6,82 to $7,09, representing a gain of 3,96% ($0,27).

The stock traded between $6,22 and $7,96 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 232,36 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

RGC 52-Week Price Position

Position in Range: 4,0%

52W Low$4,51

52W High$69,00

RGC is currently trading at $7,09, placing it 4,0% of the way from its 52-week low of $4,51 to its 52-week high of $69,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Regencell Bioscience Holdings Limited (RGC)?

Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.

Regencell Bioscience Holdings Limited Information

Employees	10
Exchange	NASDAQ
Company Website	https://www.regencellbioscience.com

How to Buy Regencell Bioscience Holdings Limited (RGC) Stock on MEXC

Eligible investors can buy real shares of Regencell Bioscience Holdings Limited (RGC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RGC and Place Your Order

Open the RealStocks trading page and search for RGC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Regencell Bioscience Holdings Limited (RGC) stock price today?

Regencell Bioscience Holdings Limited (RGC) is currently trading at $ 7,09, down 3,54% ($0,26) from the previous close of $ 7,35. Intraday prices update in real time during regular trading hours.

2.Is RGC stock going up or down today?

As of 2026-10-12 23:41:00, RGC is trading at $ 7,09, down 3,54% ($0,26) from its previous close of $ 7,35. The stock has traded between $ 0,08 and $ 83,60 during today’s regular session. Past price movements do not guarantee future results.

3.What is RGC pre-market price?

As of 2026-10-12 23:41:00, RGC is trading at $ 7,20 in pre-market trading, down 2,11% ($0,15) from the previous close of $ 7,35. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RGC after-hours price?

As of 2026-10-12 23:41:00, RGC is trading at $ 7,10 in after-hours trading, down 3,39% ($0,25) from the regular-session close of $ 7,35. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RGC stock trading now?

RGC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RGC sit relative to its 52-week high and low?

Over the past 52 weeks, RGC has traded between a low of $ 4,51 and a high of $ 69,00. At $ 7,09, the stock is positioned 4,0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited (RGC) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Regencell Bioscience Holdings Limited's market capitalisation and where is it listed?

Regencell Bioscience Holdings Limited is listed on the NASDAQ exchange with a market capitalisation of $ 3,64B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RGC valued in terms of P/E ratio and EPS?

RGC trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Regencell Bioscience Holdings Limited pay a dividend?

Regencell Bioscience Holdings Limited pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.